Sanofi (SNY) Return on Assets (2018 - 2026)

Sanofi (SNY) posted Return on Assets of 0.0% for Q2 2026, down 98.83% sequentially from 0.0% in Q1 2026, and little changed YoY from 0.0% in Q2 2025.

Sanofi (SNY) Return on Assets (2018 - 2026) Analysis & Trends

Sanofi has reported Return on Assets for 3 years, with the latest figure at 0.0% in Q2 2026.

Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets fell to 0.0% in Q2 2026 per SNY's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Assets peaked at 0.0% in Q3 2025 and troughed at 0.0% in Q2 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Johnson & Johnson	645.88 Bn	625.12 Bn	17.26 Bn	0.00%
2	AbbVie	463.46 Bn	456.89 Bn	12.70 Bn	0.00%
3	Merck	367.92 Bn	360.78 Bn	12.21 Bn	0.00%
4	Novartis Ag	297.71 Bn	290.02 Bn	11.24 Bn	-
5	Astrazeneca	255.55 Bn	250.65 Bn	12.86 Bn	0.00%
6	Amgen	234.52 Bn	220.53 Bn	7.24 Bn	0.00%
7	Gilead Sciences	178.22 Bn	175.04 Bn	6.22 Bn	0.00%
8	Pfizer	158.57 Bn	146.88 Bn	10.94 Bn	0.00%
9	Gsk	105.32 Bn	101.15 Bn	8.24 Bn	0.00%
10	Sanofi	54.20 Bn	46.82 Bn	10.79 Bn	0.01%

Download Data